MAXHEALTH · Concall Summary
MAX HEALTHCARE INS LTD
On August 17, 2026, Max Healthcare Institute Limited submitted an investor presentation in connection with its participation in the Motilal Oswal 22nd Annual Global Investor Conference. The presentation outlined the company's current capacity of over 6,100 beds across 21 facilities, emphasizing its position as India's second-largest hospital chain by revenue and EBITDA. Management highlighted key growth drivers, including a focus on expanding bed capacity through brownfield and greenfield projects, optimizing existing infrastructure, and leveraging technology. Financial highlights indicated a 15% year-over-year growth in gross revenue for Q1 FY27, with an operating EBITDA margin of 24.9%. The document also detailed the company's commitment to clinical excellence, research, and community service, alongside its strategic partnerships and digital initiatives. The presentation concluded with a focus on future growth potential and the importance of maintaining high standards in patient care.
Management emphasized growth opportunities and strong financial performance.
View source filing →Earlier concalls
- 2026-05-29 — Max Healthcare Institute Limited held its earnings conference call on May 22, 2026, to discuss financial results for Q4 …
- 2026-05-26 — On May 26, 2026, Max Healthcare Institute Limited submitted an investor presentation in connection with the UBS Asian In…
- 2026-02-20 — On February 20, 2026, Max Healthcare Institute Limited submitted an investor presentation for the upcoming Kotak Chasing…
See MAXHEALTH's full Research Pro page — annual report summary, insider trades, promoter pledge trend, options positioning and Ask-RedixFi AI.
Sign up free